BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1650530)

  • 21. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.
    Humblet Y; Symann M; Bosly A; Delaunois L; Francis C; Machiels J; Beauduin M; Doyen C; Weynants P; Longueville J
    J Clin Oncol; 1987 Dec; 5(12):1864-73. PubMed ID: 2824708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
    Navarro M; Mur E; Jolis L; Bellmunt J; Bodi R; Solé LA; Rubio D
    Rev Clin Esp; 1991 Oct; 189(5):209-12. PubMed ID: 1666192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancer.
    Chute JP; Kelley MJ; Venzon D; Williams J; Roberts A; Johnson BE
    Chest; 1996 Jul; 110(1):165-71. PubMed ID: 8681622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot studies of superfractionated radiotherapy and combination chemotherapy in limited oat cell carcinoma of the bronchus.
    Hodson DI; Malaker K; Meikle AL; Levitt M
    Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1941-5. PubMed ID: 6092307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.
    Shepherd FA; Ginsberg RJ; Feld R; Evans WK; Johansen E
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):385-93. PubMed ID: 1847981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combination chemotherapy with multimodality approaches for small cell carcinoma of the lung].
    Ohnoshi T; Hiraki S; Miyake K; Ozawa S; Kawahara S; Tamura M; Kimura I; Hiraki Y
    Gan No Rinsho; 1984 May; 30(6 Suppl):734-40. PubMed ID: 6086974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
    Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
    Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
    Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
    Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [General hyperthermia in the chemoradiotherapy of small-cell lung cancer].
    Zhavrid EA; Sachivko NV; Fradkin SZ; Rud'ko AS
    Vopr Onkol; 1991; 37(9-10):962-7. PubMed ID: 1668807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin and etoposide alternating with vincristine, doxorubicin and cyclophosphamide in patients with small cell lung cancer.
    Littlewood TJ; Smith AP; Anderson G; Chappell AG; James KW
    Eur J Respir Dis; 1985 Oct; 67(4):294-300. PubMed ID: 3000808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination chemotherapy and radiation therapy for small cell carcinoma of the lung].
    Hara N; Ichinose Y; Motohiro A; Noge S; Miyake J; Ohta M; Hata K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):80-5. PubMed ID: 3002286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of small cell carcinoma of pancreas to a small cell lung cancer regimen: a case report.
    Wahid NA; Neugut AI; Hibshoosh H; Brunetti JC; Fountain KS; Rubin M
    Cancer Invest; 1996; 14(4):335-9. PubMed ID: 8689428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung.
    Murray N; Shah A; Brown E; Kostashuk E; Laukkanen E; Goldie J; Band P; Van den Hoek J; Murphy K; Sparling T
    Semin Oncol; 1986 Sep; 13(3 Suppl 3):24-30. PubMed ID: 3020695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of late recurrence and/or second lung cancer after treatment of patients with small cell lung cancer (SCLC).
    Szczepek B; Szymańska D; Decker E; Wasowska H; Slupek A; Rowińska-Zakrzewska E
    Lung Cancer; 1994 Jul; 11(1-2):93-104. PubMed ID: 8081708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination chemotherapy and radiotherapy in small cell carcinoma of the lung].
    Yoshida S; Ogata T; Homma T; Kikuchi K; Masuda H; Matsuoka T; Sugiyama K; Noguchi Y; Yoneda S; Fukuda T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2331-6. PubMed ID: 3015041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.
    Brooks BJ; Seifter EJ; Walsh TE; Lichter AS; Bunn PA; Zabell A; Johnston-Early A; Edison M; Makuch RW; Cohen MH
    J Clin Oncol; 1986 Feb; 4(2):200-9. PubMed ID: 3003259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).
    Dautzenberg B; Chastang C; Arriagada R; Le Chevalier T; Belpomme D; Hurdebourcq M; Lebeau B; Fabre C; Charvolin P; Guérin RA
    Cancer; 1995 Sep; 76(5):779-86. PubMed ID: 8625180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term results of surgery and chemotherapy in small cell lung cancer.
    Rea F; Callegaro D; Favaretto A; Loy M; Paccagnella A; Fantoni U; Festi G; Sartori F
    Eur J Cardiothorac Surg; 1998 Oct; 14(4):398-402. PubMed ID: 9845145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.